Literature DB >> 24334429

Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery.

Tanja Nikolova, Oleg Bayev, Natasha Nikolova, Gian Carlo Di Renzo.   

Abstract

OBJECTIVE: The PartoSure time-to-delivery (TTD) test (AmniSure International, Boston, MA, USA) is a newly available bedside test for the prediction of time to spontaneous preterm delivery via the detection of placental alpha microglobulin-1. The objective of this study was to determine the efficacy of the test in predicting imminent delivery in 7 or 14 days from the time of testing.
METHODS: The study population consisted of 101 consecutively recruited pregnant women with singleton pregnancies between 20+0 and 36+6 weeks of gestation with symptoms of preterm labor, clinically intact amniotic membranes, and minimal cervical dilatation (≤3 cm). The PartoSure TTD test was performed on these patients and the test-to-spontaneous-delivery interval was calculated.
RESULTS: The PartoSure TTD test predicted spontaneous preterm delivery within 7 days with 90.0% sensitivity, 93.8% specificity, 97.4% negative predictive value (NPV), and 78.3% positive predictive value (PPV). The test predicted spontaneous preterm delivery within 14 days with 80% sensitivity, 96.1% specificity, 93.6% NPV, and 87.0% PPV.
CONCLUSION: A positive PartoSure TTD test in patients presenting with symptoms of preterm labor, intact membranes, and minimal cervical dilatation (≤3 cm) indicated spontaneous preterm delivery will occur within 7 days with a high degree of accuracy. A negative result indicated that spontaneous preterm delivery within 14 days is highly unlikely.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24334429     DOI: 10.1515/jpm-2013-0234

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  9 in total

1.  A high concentration of fetal fibronectin in cervical secretions increases the risk of intra-amniotic infection and inflammation in patients with preterm labor and intact membranes.

Authors:  Kyung Joon Oh; Roberto Romero; Jee Yoon Park; Jihyun Kang; Joon-Seok Hong; Bo Hyun Yoon
Journal:  J Perinat Med       Date:  2019-04-24       Impact factor: 1.901

2.  Exploring fetal fibronectin testing as a predictor of labour onset: In parturient women from isolated communities.

Authors:  Gwen K Healey; William Alexander Macdonald; Stefan Grzybowski; Robert Nevin; Jude Kornelsen; William E Hogg
Journal:  Can Fam Physician       Date:  2018-03       Impact factor: 3.275

3.  An elevated amniotic fluid prostaglandin F2α concentration is associated with intra-amniotic inflammation/infection, and clinical and histologic chorioamnionitis, as well as impending preterm delivery in patients with preterm labor and intact membranes.

Authors:  Jee Yoon Park; Roberto Romero; JoonHo Lee; Piya Chaemsaithong; Noppadol Chaiyasit; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-15

4.  Quantitative fetal fibronectin to predict spontaneous preterm birth: a review.

Authors:  Natasha L Hezelgrave; Andrew H Shennan
Journal:  Womens Health (Lond)       Date:  2015-12-11

5.  First-trimester vaginal microbiome diversity: A potential indicator of preterm delivery risk.

Authors:  Mohammed Monzoorul Haque; Mitali Merchant; Pinna Nishal Kumar; Anirban Dutta; Sharmila S Mande
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

6.  Use of cervicovaginal PAMG-1 protein as a predictor of delivery within seven days in pregnancies at risk of premature birth.

Authors:  Yasemin Çekmez; Gürkan Kıran; Esra Tuştaş Haberal; Merve Dizdar
Journal:  BMC Pregnancy Childbirth       Date:  2017-07-26       Impact factor: 3.007

7.  Combined value of placental alpha microglobulin-1 detection and cervical length via transvaginal ultrasound in the diagnosis of preterm labor in symptomatic patients.

Authors:  Vyacheslav Bolotskikh; Vera Borisova
Journal:  J Obstet Gynaecol Res       Date:  2017-06-14       Impact factor: 1.730

Review 8.  Antenatal steroids for fetal lung maturity: Time to target more frequent doses to fewer women?

Authors:  Carolyn I Freeman; Natasha L Hezelgrave; Andrew H Shennan
Journal:  Obstet Med       Date:  2015-09-21

9.  The value of a vaginal sample for detecting PAMG-1 (Partosure®) in women with a threatened preterm delivery (the MAPOSURE Study): protocol for a multicenter prospective study.

Authors:  Emilie Marie; Guillaume Ducarme; Marion Boivin; Virginie Badon; Hélène Pelerin; Aurélie Le Thuaut; Zeineb Lamoureux; Valéry-Pierre Riche; Norbert Winer; Thibault Thubert; Vincent Dochez
Journal:  BMC Pregnancy Childbirth       Date:  2020-08-03       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.